Literature DB >> 10591404

EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity.

H Kabuto1, I Yokoi, E Iwata-Ichikawa, N Ogawa.   

Abstract

We examined the effect of pretreatment with EPC-K1, a potent hydroxyl radical scavenger, on 6-hydroxydopamine (6-OHDA)-induced reduction of dopamine (DA) and its metabolites in the mouse striatum. EPC-K1 was mixed with diet (0.2%, wt/wt) for 1 or 2 weeks, and then 6-OHDA (60 microg in 2 microl of saline solution) was injected intracereberoventricularly. Mice continued to be fed EPC-K1-containing diet for another one week before they were sacrificed. The concentrations of DA and its metabolites in the striatum were measured by high performance liquid chromatography. 6-OHDA reduced the level of DA and its metabolites in the striatum. Pretreatment with EPC-K1 for 2 weeks, but not for 1 week, abrogated the neurotoxic effect of 6-OHDA on striatal concentrations of DA and its metabolites. Measurement of striatal concentrations of thiobarbituric acid reactive substances, glutathione, and malonaldehyde plus 4-hydroxynonenal, and the activities of superoxide dismutase and catalase in EPC-K1 treated mice showed an increase in catalase activity after 2 weeks of such treatment. No other changes in anti-oxidants levels were noted. Our results suggest that EPC-K1 counteracts the neurotoxicity of 6-OHDA by increasing catalase activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591404     DOI: 10.1023/a:1021152115752

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

Review 1.  Parkinson's disease and free radicals. Mechanism of neurodegeneration and neuroprotection.

Authors:  T Kondo
Journal:  Ann N Y Acad Sci       Date:  1996-06-15       Impact factor: 5.691

2.  In vitro studies of ferritin iron release and neurotoxicity.

Authors:  K L Double; M Maywald; M Schmittel; P Riederer; M Gerlach
Journal:  J Neurochem       Date:  1998-06       Impact factor: 5.372

Review 3.  Melatonin as a free radical scavenger: implications for aging and age-related diseases.

Authors:  R J Reiter; D X Tan; B Poeggeler; A Menendez-Pelaez; L D Chen; S Saarela
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

Review 4.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

5.  Evaluation of the antioxidant activity of melatonin in vitro.

Authors:  K A Marshall; R J Reiter; B Poeggeler; O I Aruoma; B Halliwell
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

7.  Free radical-generated neurotoxicity of 6-hydroxydopamine.

Authors:  R Kumar; A K Agarwal; P K Seth
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

8.  A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.

Authors:  S Fahn
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

9.  Localization of damage induced by reactive oxygen species in cultured cells.

Authors:  S M Vroegop; D E Decker; S E Buxser
Journal:  Free Radic Biol Med       Date:  1995-02       Impact factor: 7.376

10.  In vitro studies on the influence of L-ascorbic acid 2-[3,4-dihydro- 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6yl-hy drogen phosphate] potassium salt on lipid peroxidation and phospholipase A2 activity.

Authors:  Y Kuribayashi; K Yoshida; T Sakaue; A Okumura
Journal:  Arzneimittelforschung       Date:  1992-09
View more
  4 in total

1.  Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Authors:  Javier Iglesias-González; Sofía Sánchez-Iglesias; Estefanía Méndez-Álvarez; Sarah Rose; Atsuko Hikima; Peter Jenner; Ramón Soto-Otero
Journal:  Neurochem Res       Date:  2012-07-22       Impact factor: 3.996

2.  Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum.

Authors:  Hideaki Kabuto; Masahiro Nishizawa; Mika Tada; Chie Higashio; Tsuyoshi Shishibori; Masahiro Kohno
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

3.  Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.

Authors:  Hideaki Kabuto; Tomoko T Yamanushi
Journal:  Neurochem Res       Date:  2011-07-19       Impact factor: 3.996

4.  Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.

Authors:  Jason Callio; Tim D Oury; Charleen T Chu
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.